varenicline has been researched along with Anxiety in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 3 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Ebrahimi-Kalan, A; Farhoudi, M; Hosseini, L; Kazmi, S; Mahmoudi, J; Rahbarghazi, R; Sadigh-Eteghad, S; Seyedaghamiri, F; Shanehbandi, D | 1 |
| Ashare, RL; Bauer, AM; Flitter, A; Gross, R; Leone, F; Lubitz, SF; Quinn, MH; Schnoll, R; Thompson, M | 1 |
| Ashare, RL; Collman, RG; Gross, R; Leone, F; Schnoll, R; Serrano, K; Thompson, M | 1 |
| Cann, C; Gould, TJ; Kutlu, MG; Tumolo, JM | 1 |
| Bancroft, EA; DuBois, DW; Fincher, AS; Migut, EA; Montgomery, KS; Murchison, D; Provasek, V | 1 |
| de Abreu, GR; de Souza Spinosa, H; Faria Waziry, PA; Flório, JC; Fukushima, AR; Lebrun, I; Moreira, N; Petrocelli, BM; Reis-Silva, TM; Ricci, EL; Sandini, TM; Zaccarelli-Magalhães, J | 1 |
| Blendy, JA; Carlson, GC; Gould, TJ; Poole, RL; Turner, JR; Wilkinson, DS | 1 |
| Anthenelli, RM; Dubrava, SJ; Morris, C; Ramey, TS; Russ, C; Tsilkos, K; Yunis, C | 1 |
| Blendy, JA; DeDominicis, KE; Forcelli, PA; Hussmann, GP; Kellar, KJ; Klehm, J; Lindstrom, J; Richardson, JR; Sahibzada, N; Turner, JR; Wolfe, BB; Xiao, Y; Yasuda, RP | 1 |
| Davies, NM; Martin, RM; Munafò, MR; Taylor, AE; Taylor, G; Thomas, KH; Windmeijer, F | 1 |
| D'Souza, G; Kim, D; McGregor, AL; Tingle, MD | 1 |
| Blendy, JA; Castellano, LM; Turner, JR | 1 |
| Chatterjee, A; Garza, D; Murphy, M; Riordan, HJ; Tseng, LJ | 1 |
3 trial(s) available for varenicline and Anxiety
| Article | Year |
|---|---|
The effect of varenicline on mood and cognition in smokers with HIV.
Topics: Adult; Affect; Anxiety; Cigarette Smoking; Cognition; Female; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Smokers; Smoking Cessation; Smoking Cessation Agents; Varenicline; Young Adult | 2020 |
Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Benzazepines; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicidal Ideation; Treatment Outcome; Varenicline; Young Adult | 2013 |
A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
Topics: Adolescent; Adult; Aged; Aggression; Anxiety; Benzazepines; Depression; Double-Blind Method; Female; Humans; Irritable Mood; Male; Middle Aged; Nicotinic Agonists; Pilot Projects; Psychiatric Status Rating Scales; Quinoxalines; Smoking; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome; Varenicline | 2011 |
11 other study(ies) available for varenicline and Anxiety
| Article | Year |
|---|---|
Varenicline improves cognitive impairment in a mouse model of mPFC ischemia: The possible roles of inflammation, apoptosis, and synaptic factors.
Topics: Animals; Anxiety; Apoptosis; Behavior, Animal; Brain Ischemia; Cognitive Dysfunction; Disease Models, Animal; Mice; Neuroinflammatory Diseases; Nicotinic Agonists; Prefrontal Cortex; Synapses; Varenicline | 2022 |
Correlates of varenicline adherence among smokers with HIV and its association with smoking cessation.
Topics: Adult; Aged; Anxiety; Correlation of Data; Depression; Female; HIV Infections; Humans; Male; Medication Adherence; Middle Aged; Nicotinic Agonists; Randomized Controlled Trials as Topic; Sleep Initiation and Maintenance Disorders; Smoking Cessation; Tobacco Smoking; Varenicline | 2020 |
Differential effects of α4β2 nicotinic receptor antagonists and partial-agonists on contextual fear extinction in male C57BL/6 mice.
Topics: Animals; Anxiety; Azetidines; Dihydro-beta-Erythroidine; Disease Models, Animal; Extinction, Psychological; Fear; Male; Mice; Mice, Inbred C57BL; Nicotinic Agonists; Nicotinic Antagonists; Pyridines; Receptors, Nicotinic; Stress Disorders, Post-Traumatic; Varenicline | 2018 |
Effects of ethanol and varenicline on female Sprague-Dawley rats in a third trimester model of fetal alcohol syndrome.
Topics: Animals; Anxiety; Basal Forebrain; Disease Models, Animal; Ethanol; Excitatory Postsynaptic Potentials; Female; Fetal Alcohol Spectrum Disorders; Male; Maze Learning; Motor Activity; Pregnancy; Pregnancy Trimester, Third; Rats; Varenicline | 2018 |
Prolonged exposure of rats to varenicline increases anxiety and alters serotonergic system, but has no effect on memory.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Analysis of Variance; Animals; Anxiety; Behavior, Animal; Cognition; gamma-Aminobutyric Acid; Hippocampus; Male; Memory; Models, Animal; Motor Activity; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Serotonergic Neurons; Serotonin; Smoking; Smoking Cessation; Varenicline | 2019 |
Divergent functional effects of sazetidine-a and varenicline during nicotine withdrawal.
Topics: Animals; Anxiety; Azetidines; Benzazepines; Cerebral Cortex; Dose-Response Relationship, Drug; Drug Partial Agonism; Evoked Potentials; Hippocampus; Male; Mice; Microinjections; Motor Activity; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Receptors, Nicotinic; Smoking Cessation; Substance Withdrawal Syndrome; Up-Regulation; Varenicline | 2013 |
Summaries for patients. Does varenicline help people with depression quit smoking?
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Benzazepines; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; Nicotinic Agonists; Quinoxalines; Smoking Cessation; Suicidal Ideation; Treatment Outcome; Varenicline; Young Adult | 2013 |
Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Azetidines; Benzazepines; Brain Chemistry; Drug Evaluation, Preclinical; Feeding Behavior; Gene Expression Regulation; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Substance Withdrawal Syndrome; Tobacco Use Cessation; Tobacco Use Disorder; Up-Regulation; Varenicline; Weight Gain | 2014 |
What are the effects of varenicline compared with nicotine replacement therapy on long-term smoking cessation and clinically important outcomes? Protocol for a prospective cohort study.
Topics: Anxiety; Depression; Humans; Logistic Models; Multivariate Analysis; Nicotinic Agonists; Prospective Studies; Psychiatric Status Rating Scales; Research Design; Smoking; Smoking Cessation; Socioeconomic Factors; Suicide; Tobacco Use Cessation Devices; Varenicline | 2015 |
Varenicline improves motor and cognitive deficits and decreases depressive-like behaviour in late-stage YAC128 mice.
Topics: Animals; Anxiety; Cell Proliferation; Cognition Disorders; Corpus Striatum; Depression; Disease Models, Animal; Female; Hippocampus; Huntington Disease; Male; Maze Learning; Memory; Mice, Transgenic; Motor Activity; Movement Disorders; Neural Stem Cells; Neuroprotective Agents; Nicotinic Agonists; Varenicline | 2017 |
Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.
Topics: Animals; Anxiety; Azetidines; Behavior, Animal; Benzazepines; Chimera; Depression; Drug Partial Agonism; Male; Mice; Mood Disorders; Nicotine; Nicotinic Agonists; Pyridines; Quinoxalines; Varenicline | 2010 |